Section 01The State of Healthcare in AI Answers

Healthcare buyers — patients, providers, payers, and investors — now begin research inside AI engines. A patient researching a new diagnosis asks ChatGPT for treatment options. A physician researching a new drug class asks Claude for the mechanism of action and the trial data. An institutional investor researching a biotech asks Perplexity for the pipeline and the regulatory timeline. A hospital IT committee researching an EHR vendor asks Gemini for the comparative landscape.

The answer engines reach for a narrow, distinctive set of sources to construct healthcare answers — FDA, NIH/PubMed, Mayo Clinic, Cleveland Clinic, WebMD, Healthline, Drugs.com, NEJM, Lancet, JAMA, STAT News, Endpoints News, BioPharma Dive, plus the institutional review layer that varies by sub-category (KLAS Research for healthcare IT, peer-reviewed dermatology journals for aesthetics, oncology meeting proceedings for cancer).

Healthcare brands present on those surfaces accumulate Citation Share. Brands absent from them are invisible at the moment of decision-making — a structural problem that traditional healthcare PR was never designed to solve. The healthcare funnel has compressed from three decades of long-sequence research into a single AI-mediated moment.

Section 02Who AI Cites in Healthcare

The composite retrieval-anchor stack for healthcare across the five major engines, by sub-category. For the full top-25 brand ranking — Mayo Clinic at 9.4, Cleveland Clinic at 7.1, Johns Hopkins at 6.8, WebMD at 5.9, Healthline at 5.4, NIH/MedlinePlus at 5.2 — see the EPR Healthcare Citation Share Index 2026.

The structural finding. Healthcare retrieval is more government-anchored and more peer-review-anchored than any other consumer-adjacent category EPR has modeled. FDA, NIH/PubMed, and the major academic-medicine institutions collectively form the foundation on which everything else builds. Sub-categories then layer specialized peer-review and institutional infrastructure — KLAS for healthcare IT, dermatology journals for aesthetics, oncology meetings for cancer. The 5W Retrieval Index Edition 22 grades digital health and healthtech a B because the dedicated trade press tier is fragmented; the institutional and government layer underneath is strong.

Section 03Healthcare AI Visibility — The Two-Layer Discipline

Healthcare PR programs running only trade-press outreach are leaving half the AI citation prize unclaimed. The 2026 cross-industry research finds that Perplexity rewards NIH and PubMed primary sources more than any trade publication — meaning a brand that masters STAT and Endpoints but ignores the peer-reviewed evidence base is invisible on half the engines.

The discipline is two-layered. Trade-press authority drives ChatGPT, Gemini, and AI Overviews on industry-news queries. Peer-reviewed clinical evidence drives Perplexity and Claude on clinical-fact queries. Brands compounding Citation Share build infrastructure on both layers simultaneously. See: AI Communications for Healthcare · Healthcare GEO: Why It Replaced Healthcare SEO.

Section 04The Regulatory Layer

No communications category is more heavily regulated. FDA promotional guidelines govern what pharmaceutical and medical device companies can say about their products, to whom, and in what format. HIPAA constrains patient communications. FTC truth-in-advertising standards apply to consumer health claims. State insurance regulations constrain health plan marketing. The result is a communications discipline where every message requires legal review and where the cost of regulatory violation is measured in enforcement actions, consent decrees, and Congressional testimony.

The AI era adds a new regulatory dimension. When AI engines surface health information in response to patient queries — which drugs treat a condition, which hospitals have the best outcomes, which digital health app is most effective — the regulatory and communications teams must understand how their content enters the AI answer layer and how to correct errors without triggering promotional review concerns. See: Who Controls the Healthcare Narrative When AI Generates the Answer.

Section 05What Healthcare PR Firms Do

Healthcare PR operates across a broader range of audience types, regulatory constraints, and communications objectives than almost any other specialty. A hospital system communicating with patients, a pharmaceutical company communicating with prescribers and payers, a digital health startup communicating with enterprise buyers, and a biotech communicating with investors and the FDA — all four are "healthcare PR" and all four require entirely different playbooks.

Hospital and health system communications. Reputation management, patient acquisition communications, physician recruitment, community health programs, crisis response (patient safety incidents, data breaches, regulatory actions), and the AI visibility layer where patients now research hospitals before selecting a provider.

Pharmaceutical communications. Pre-approval product communications, FDA advisory committee strategy, post-approval brand launch, disease awareness programs, DTC advertising compliance, physician education programs, patient advocacy partnerships, pricing and access communications, and the full scope of regulatory affairs communications. Full coverage: The Pharma Hub · Pharma AI Citation Share Study.

Medical device communications. FDA 510(k) and PMA clearance communications, clinical trial results, physician and hospital buyer communications, patient safety communications.

Digital health and health tech. The fastest-growing segment of healthcare PR. Telehealth, health IT, remote patient monitoring, AI diagnostics, pharmacy technology, consumer health apps — see the structural retrieval map of the category and how Zocdoc became the AI front door for healthcare.

Medical aesthetics. The $22 billion category covering neurotoxins, dermal fillers, energy-based devices, medical-grade skincare, and surgical procedures. Botox, Juvéderm, CoolSculpting, SkinCeuticals, and Morpheus8 lead AI citation share; GLP-1 demand is remaking the category.

Biotech and life sciences. Clinical trial results communications, investor relations support, partnership and licensing deal announcements, FDA interaction communications, and the long runway of credibility-building that precedes a major product approval.

Section 06Pharma Brand Coverage

The defining brand cases EPR has covered across the pharmaceutical industry — wired from this Healthcare coverage into the dedicated Pharma cluster.

• Pharma Hub — Pfizer, Eli Lilly, J&J, Purdue, Moderna, GLP-1
• The Pharma AI Citation Share Study
• Eli Lilly: The GLP-1 Brand Demand Leader
• GLP-1: Ozempic, Wegovy, Mounjaro, Zepbound — The Communications Brief
• Johnson & Johnson: Tylenol Hero, Talc Villain
• Purdue Pharma & the Sacklers: The Largest Reputation Collapse in U.S. Pharma History
• Moderna's Post-COVID Reputation Reset
• WebMD Is Losing to Reddit on Drug Questions

Section 07The Top Healthcare PR Firms

Real Chemistry — The largest U.S. healthcare communications firm by revenue (~$560M, ~2,110 employees). Strongest integrated data and AI capability in the category. 2025 PRWeek US Outstanding Healthcare Agency of the Year.

Havas Health & You — Havas Group's global healthcare communications network. 30+ offices worldwide. CEO Donna Murphy. Strong on pharmaceutical brand communications and patient engagement programs.

Lippe Taylor (now /prompt) — Independent New York-based healthcare, consumer-health, and women's-brands specialist. CEO Paul Dyer. Rebranded as /prompt April 2026 following merger with twelvenote.

Spectrum Science — Leading independent health and science PR agency. CEO Jonathan Wilson. Practice areas: biotechnology, biopharma, health technology, public affairs, consumer science.

IMRE — Founded 1993. Healthcare and life sciences specialty. LGBTQ+-founded, PE-backed independent.

5W AI Communications — Health & Wellness practice with AI Communications integration — Citation Share measurement and GEO for healthcare brands competing inside the AI answer layer. Publisher of the 5W Retrieval Index Edition 22 and producer of the Medical Aesthetics AI Visibility Index 2026 with Haute MD.

Repugen — HIPAA-compliant healthcare-specialist reputation management SaaS. Founded 2016 by Ajay Prasad. Positioned across reputation, patient satisfaction, and AI visibility for medical practices.

Section 08Crisis Communications in Healthcare

Healthcare crisis communications is its own sub-specialty. Product safety issues, recalls, clinical trial failures, FDA warning letters, data breaches under HIPAA, hospital adverse events, and executive misconduct all require crisis protocols that simultaneously satisfy regulatory disclosure requirements, patient safety communication obligations, legal counsel guidance, and media response frameworks.

The AI era extends the crisis timeline. AI engines persist healthcare crisis narratives for 12-18 months, replacing the traditional news-cycle half-life. The new response window is 2-4 weeks. Source dominance beats message dominance. Building the corrective record into the AI citation layer is now a mandatory component of healthcare crisis recovery.

For the full crisis playbook: Crisis PR Hub · Top Crisis PR Firms 2026.

Section 09What Moves Healthcare Citation Share

1. FDA documentation acknowledgment. Products and methodologies named in FDA guidance documents, clearance letters, breakthrough-device designations, or advisory committee proceedings receive durable citation that persists beyond the publication cycle.
2. Peer-reviewed clinical evidence. Studies indexed in PubMed and published in NEJM, Lancet, JAMA, and the specialty journals (Annals of Oncology, Circulation, Diabetes Care, JAAD, etc.) drive Perplexity and Claude retrieval on clinical-fact queries.
3. Mayo Clinic and Cleveland Clinic mention. Coverage in patient-facing content from the academic medical anchors compounds across ChatGPT, Gemini, and AI Overviews.
4. STAT News and Endpoints News coverage. The two dominant pharma/biotech trade publications drive Perplexity and Claude citation on industry-news queries.
5. KLAS positioning (for healthcare-IT vendors). Best in KLAS and Category Leader recognitions function as the single highest retrieval lever in the healthcare-IT sector.
6. Clinical-authority editorial (for medical aesthetics and consumer health). Board-certified specialist commentary in Haute MD, Allure, Vogue dermatology, and peer-reviewed dermatology coverage anchors brand citation.
7. Original research with public methodology. Annual reports — the equivalent of the Verizon DBIR in cyber — produce durable category citation.
8. Wikipedia entity accuracy. Healthcare conditions, drugs, devices, and institutions are heavily retrieved from Wikipedia. Entity-page accuracy is a primary deliverable, not an afterthought.

Section 10What This Means

For healthcare brands, the AI visibility layer now mediates patient research, provider research, payer research, and investor research simultaneously. Brands that built earlier-era infrastructure — DTC advertising, trade-press relationships, medical conference sponsorship — still benefit from those investments, but the durable Citation Share advantage now accrues to brands building the two-layer discipline: peer-reviewed evidence base AND trade-press authority, simultaneously.

For healthcare PR firms, the new client expectation is integrated capability across earned media, regulatory communications, and AI visibility measurement. Firms that treat AI visibility as a separate function or outsource it lose the integrated mandate to firms that operate it as a core practice.

For healthcare regulators and policymakers, the AI answer layer is now part of the public information infrastructure. The accuracy of AI-generated healthcare information — and the corrective mechanisms when AI engines surface errors — is a regulatory question, not just a communications one.

FAQFrequently Asked Questions